ECM drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| ECM | interacts_with | β-amyloid | — | 1 |
Mentioned in (8)
Papers in which this entity is mentioned.
- Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma. (2023)
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease. (2020)
- Efficient derivation of microglia-like cells from human pluripotent stem cells. (2016)
- Myeloid cells in tumor inflammation. (2012)
- Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. (2011)
- A random cell motility gradient downstream of FGF controls elongation of an amniote embryo. (2010)
- Perlecan controls neurogenesis in the developing telencephalon. (2007)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ecm | drug | 8 | 9 |